We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,401

Attorney General Sessions Memo Frees Federal Prosecutors to Pursue Marijuana Cases - What Does It Mean for Broadcast Advertisements?
  • Wilkinson Barker Knauer LLP
  • USA
  • January 5 2018

Yesterday, Attorney General Jeff Sessions issued a one-page memo (here) advising Federal prosecutors to use their discretion in pursuing marijuana


Regulatory Roundup - December 2017
  • Crowell & Moring LLP
  • USA
  • December 20 2017

On October 26, 2017, CPSC issued a Final Decision and Order holding that Zen Magnets and Neoballs rare-earth magnet sets (Zen Magnets) are a


Regulators Setting Crosshairs on Unproven Homeopathic Products
  • Bereskin & Parr LLP
  • USA, Canada
  • December 19 2017

Homeopathic products are a growing industry. As more products hit the market, and their popularity increases, regulators in the United States and


FDA Harshes the Vibe of CBD Makers, Warns Them to Stop Making Drug Claims
  • Venable LLP
  • USA
  • December 14 2017

While there are many questions surrounding the regulation of marijuana and related products, the FDA has made it clear where it stands on at least one


FDA Releases Guidance on Menu Labeling and Calorie Disclosure Requirements
  • Lewis Rice LLC
  • USA
  • November 11 2017

After several delays, the Food and Drug Administration (FDA) plans to enforce regulations that require disclosure of nutrition information for menu


FDA Issues Warning to Four Companies Marketing Cannabidiol Containing Products as Anti-Cancer Treatment
  • FisherBroyles LLP
  • USA
  • November 6 2017

On November 1, 2017, the U.S. Food and Drug Administration issued warning letters to four companies that were illegally marketing and selling products


No Love Lost for FDA Over Granola Ingredients
  • Manatt Phelps & Phillips LLP
  • USA
  • October 26 2017

The Food and Drug Administration showed no love for Nashoba Brook Bakery’s granola by sending a letter to the Massachusetts business instructing it to


FDA Issues New Guidance on E-Cigarette Free Samples
  • Klein Moynihan Turco LLP
  • USA
  • October 18 2017

Last week, the Food and Drug Administration (“FDA”) issued finalized guidance regarding the distribution of free samples of e-cigarettes and other


Update: New Advertising Disclaimers on E-Cig and Cigar Advertising Still on for 2018
  • Wilkinson Barker Knauer LLP
  • USA
  • October 13 2017

Last year, the FDA adopted requirements to tag advertisements for vaping and e-cig advertising with a warning that e-cigs contain nicotine and that


Insys Therapeutics Runs Afoul of Attorneys General in Two States
  • FisherBroyles LLP
  • USA
  • October 10 2017

Arizona-based pharmaceutical company Insys Therapeutics Inc. (Insys) has found itself under investigation in both Massachusetts and New Jersey over